Trial of AD113 and Atomoxetine in OSA Patients With Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a randomized, double blind, 2-period, non placebo-controlled crossover study in patients with moderate to severe OSA and controlled hypertension, comparing atomoxetine with AD113
Epistemonikos ID: 27c722925b252b1a3341dd42f2ad946a88c81fbf
First added on: May 08, 2024